Provided by Tiger Trade Technology Pte. Ltd.

Autolus Therapeutics PLC

1.88
-0.0800-4.08%
Post-market: 1.910.0300+1.60%16:45 EDT
Volume:1.72M
Turnover:3.27M
Market Cap:500.35M
PE:-1.79
High:1.98
Open:1.98
Low:1.87
Close:1.96
52wk High:2.58
52wk Low:1.18
Shares:266.14M
Float Shares:104.00M
Volume Ratio:0.92
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0526
EPS(LYR):-1.0804
ROE:-133.00%
ROA:-25.44%
PB:6.69
PE(LYR):-1.74

Loading ...

Autolus Highlights ALL Opportunity and AUCATZYL CAR-T Platform

TIPRANKS
·
Apr 09

Autolus to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 07

Autolus Therapeutics Balances Growth Ambition With Rising Losses

TIPRANKS
·
Apr 01

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Mar 31

Autolus: Transition-Year Execution and Aucatzyl Expansion Underscore Buy-Rated Long-Term Upside

TIPRANKS
·
Mar 28

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
Mar 27

Autolus Therapeutics PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 27

Autolus Highlights AUCATZYL Launch and Pipeline Advancements

TIPRANKS
·
Mar 27

Autolus Therapeutics FY2025 net loss widens 30.3% to $(288) million; revenue rises to $75 million

Reuters
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 27

Autolus Therapeutics PLC expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
Mar 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 25

Autolus Therapeutics plc Director Ryan Richardson Files Initial Beneficial Ownership Statement

Reuters
·
Mar 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23

Autolus Therapeutics plc files initial beneficial ownership statement for U.S. CCO and Country General Manager Cintia Piccina

Reuters
·
Mar 19

Autolus Therapeutics files Form 3 initial beneficial ownership statement for Director Rao Madduri Ravin

Reuters
·
Mar 19

Autolus Therapeutics files Form 3 initial beneficial ownership statement for Director Michael W Bonney

Reuters
·
Mar 19

Autolus Therapeutics director Linda Bain files initial beneficial ownership statement

Reuters
·
Mar 19

Autolus Therapeutics plc Director John E. Berriman Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Autolus Therapeutics plc files Form 3 as SVP, Legal Affairs and GC Alex Driggs reports beneficial ownership

Reuters
·
Mar 19